Skip to content
The GLP-1 Verdict
Menu
Ranked #388 · Grade C

Peter MD review

A physician-prescribed telehealth brand with tiered semaglutide pricing and a discounted tirzepatide first month — restrictions vary by treatment, excluding several states, and its own marketing page understates them.

Visit Peter MD Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$149/mo first-time, $139/mo returning
Tirzepatide
$149 first month, then $249/mo thereafter, billed quarterly
Coverage
Most states — excludes AL, ID and up to 5 more depending on treatment
Brand-name
Compounded only

The scorecard

Peter MD scored on our six published factors. See the methodology.

Real-world results58/100
Price honesty42/100
Prescriber access60/100
Formulary choice45/100
Cancellation fairness50/100
Member support55/100

What we like

  • Physician-prescribed telehealth model, founded 2021, headquartered in Miami, FL
  • Semaglutide is priced in two published tiers, and returning patients pay less than first-time patients ($139/mo vs $149/mo)
  • Tirzepatide's discounted first month ($149) is stated up front rather than buried in fine print

The caveats

  • The affiliate program's own disclosed restricted-state list is broader than the customer-facing pricing pages: tirzepatide is additionally excluded in AR, CA, MI, NC and TX beyond the AL/ID the marketing page names, and the two disclosures do not agree
  • Tirzepatide's price nearly doubles after the first month, from $149 to $249/mo, billed quarterly
  • Semaglutide is sold combined with B12 as "GLP1 + B12," not offered as a standalone prescription
  • No oral or sublingual option — injectable only
  • Customer reviews are mixed

The verdict

Best for: Patients outside the excluded states who want tiered semaglutide pricing or a discounted tirzepatide first month from a physician-founded telehealth brand. A physician-prescribed telehealth brand with tiered semaglutide pricing and a discounted tirzepatide first month — restrictions vary by treatment, excluding several states, and its own marketing page understates them.

Ranked #388 of 502 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between TideMedix, 55/100 above and BodyLogicMD at 54/100 below, with the CaliberRx ruling the next one down.

If that ruling leaves you undecided, the 7 programmes we rank against Peter MD are graded on the same six factors and listed in score order. We have also ruled on it directly: CoreAge Rx vs Peter MD goes to CoreAge Rx, 94/100 to 52/100.

Visit Peter MD

Compare with other providers

All 501 other providers we've reviewed, in our overall ranking order.

Every other program we track (495)

Pricing, states and verification reflect Peter MD's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Peter MD's site. Not medical advice; see our disclosure.

← Back to all rankings